Insulin resistance is associated with lower arterial blood flow and reduced cortical perfusion in cognitively asymptomatic middle-aged adults

Journal of Cerebral Blood Flow and Metabolism

Volumn 37, Issue 6, 2017, Pages 2249-2261

  Hoscheidt, Siobhan M ^a   Kellawan, J Mikhail ^b   Berman, Sara E ^a   Rivera Rivera, Leonardo A ^a,b   Krause, Rachel A ^a   Oh, Jennifer M ^a   Beeri, Michal S ^c,d   Rowley, Howard A ^a,b   Wieben, Oliver ^a,b   Carlsson, Cynthia M ^a,e   Asthana, Sanjay ^a,e   Johnson, Sterling C ^a,e   Schrage, William G ^b   Bendlin, Barbara B ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c SHEBA MEDICAL CENTER   (Israel)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

Author keywords

Alzheimer s; Arterial spin labeling; Cerebral blood flow; Cerebrovascular disease; Diabetes

Indexed keywords

APOLIPOPROTEIN E4; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; CONTRAST MEDIUM;

ADULT; ARTERIAL SPIN LABELING; ARTERY BLOOD FLOW; ARTICLE; BLOOD PRESSURE; BRAIN PERFUSION; BRAIN REGION; CARDIOVASCULAR RISK; COGNITION; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SEQUENCE; FEMALE; GENOTYPE; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; IMAGE PROCESSING; INSULIN RESISTANCE; INTERNAL CAROTID ARTERY; MALE; MEAN ARTERIAL PRESSURE; METABOLIC SYNDROME X; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPHYGMOMANOMETRY; AGED; BIOLOGICAL MODEL; BLOOD FLOW VELOCITY; BRAIN ARTERY; BRAIN CIRCULATION; DEMENTIA; DIAGNOSTIC IMAGING; METABOLISM; PATHOPHYSIOLOGY; PERFUSION; PHYSIOLOGY;

AGED; BLOOD FLOW VELOCITY; CEREBRAL ARTERIES; CEREBROVASCULAR CIRCULATION; COGNITION; CONTRAST MEDIA; DEMENTIA; FEMALE; HUMANS; INSULIN RESISTANCE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PERFUSION;

EID: 85019756914     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1177/0271678X16663214     Document Type: Article

References (44)

1. DeCarli C, Miller BL, Swan GE, et al. Predictors of brain morphology for the men of NHLBI twin study. Stroke 1999; 30: 529–536.
2. Raz N, Lindenberger U, Rodrigue KM, et al. Regional brain changes in aging healthy adults: general trends, individual differences and modifiers. Cereb Cortex 2005; 15: 1676–1689.
3. Raz N, Rodrigue KM, Kennedy KM, et al. Vascular health and longitudinal changes in brain and cognition in middle-aged and older adults. Neuropsychology 2007; 21: 149–157.
4. Biagi L, Abbruzzese A, Bianchi MC, et al. Age dependence of cerebral perfusion assessed by magnetic resonance continuous arterial spin labeling. J Magn Reson Imaging 2007; 25: 696–702.
5. Zarrinkoob L, Ambarki K, Wahlin A, et al. J. Blood flow distribution in cerebral arteries. J Cereb Blood Flow Metab 2015; 35: 648–654.
6. Birdsill AC, Carlsson CM, Willette AA, et al. Low cerebral blood flow is associated with lower memory function in metabolic syndrome. Obesity 2013; 21: 1313–1320.
7. Launer LJ, Lewis CE, Schreiner PJ, et al. Vascular factors and multiple measures of early brain health: CARDIA brain MRI study. PLoS One 2015; 10: e0122138.
8. Birdsill AC, Koscik RL, Jonaitis EM, et al. Regional white matter hyperintensities: aging, Alzheimer’s disease risk, and cognitive function. Neurobiol Aging 2014; 35: 769–776.
9. Okonkwo OC, Xu G, Oh JM, et al. Cerebral blood flow is diminished in asymptomatic middle-aged adults with maternal history of Alzheimer’s disease. Cereb Cortex 2014; 24: 978–988.
10. Rivera-Rivera LA, Turski P, Johnson KM, et al. 4D flow MRI for intracranial hemodynamics assessment in Alzheimer’s disease. J Cereb Blood Flow Metab. Epub ahead of print 25 November 2015. DOI: 10.1177/0271678X15617171.
11. Wang Z, Das SR, Xie SX, et al. Arterial spin labeled MRI in prodromal Alzheimer’s disease: a multi-site study. Neuroimage Clin 2013; 2: 630–636.
12. Hughes TM, Craft S. The role of insulin in the vascular contributions to age-related dementia. Biochim Biophys Acta 2016; 1862: 983–991.
13. Berman SE, Rivera-Rivera LA, Clark LR, et al. Intracranial arterial 4D-flow is associated with metrics of brain health and Alzheimer’s disease. Alzheimers Dement 2015; 1: 420–428.
14. Roher AE, Tyas SL, Maarouf CL, et al. Intracranial atherosclerosis as a contributing factor to Alzheimer’s disease dementia. Alzheimers Dement 2011; 7: 436–444.
15. Crane PK, Walker R, Hubbard RA, et al. Glucose levels and risk of dementia. N Engl J Med 2013; 369: 540–548.
16. Ronnemaa E, Zethelius B, Lannfelt L, et al. Vascular risk factors and dementia: 40-year follow-up of a population-based cohort. Dement Geriatr Cogn Disord 2011; 31: 460–466.
17. Willette AA, Xu G, Johnson SC, et al. Insulin resistance, brain atrophy, and cognitive performance in late middle-aged adults. Diabetes Care 2013; 36: 443–449.
18. Willette AA, Johnson SC, Birdsill AC, et al. Insulin resistance predicts brain amyloid deposition in late middle-aged adults. Alzheimers Dement 2015; 11: 504–510 e1.
19. Kivipelto M, Ngandu T, Fratiglioni L, et al. Obesity and vascular risk factors at midlife and the risk of demnetia and Alzheimer disease. Arch Neurol 2005; 62: 1556–1560.
20. Viticchi G, Falsetti L, Buratti L, et al. Metabolic syndrome and cerebrovascular impairment in Alzheimer’s disease. Int J Geriatr Psychiatry 2015; 30: 1164–1170.
21. Gu T, Korosec FR, Block WF, et al. PC VIPR: a high-speed 3D phase-contrast method for flow quantification and high-resolution angiography. AJNR Am J Neuroradiol 2005; 26: 743–749.
22. Johnson KM, Lum DP, Turski PA, et al. Improved 3D phase contrast MRI with off-resonance corrected dual echo VIPR. Magn Reson Med 2008; 60: 1329–1336.
23. McKhann GM, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984; 34: 939–944.
24. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011; 7: 263–269.
25. Kawas CH, Segal J, Stewart WF, et al. A validation study of the dementia questionnaire. Arch Neurol 1994; 51: 901–906.
26. Circulation. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Int. Atherosclerosis Society; and Int. Association for the Study of Obesity, 2009
27. Xu G, Rowley HA, Wu G, et al. Reliability and precision of pseudo-continuous arterial spin labeling perfusion MRI on 3.0 T and comparison with 15O-water PET in elderly subjects at risk for Alzheimer’s disease. NMR Biomed 2010; 23: 286–293.
28. Liu J, Redmond MJ, Brodsky EK, et al. Generation and visualization of four-dimensional MR angiography data using an undersampled 3-D projection trajectory. IEEE Trans Med Imaging 2006; 25: 148–157.
29. Stalder AF, Russe MF, Frydrychowicz A, et al. Quantitative 2D and 3D phase contrast MRI: optimized analysis of blood flow and vessel wall parameters. Magn Reson Med 2008; 60: 1218–1231.
30. Okonkwo OC, Xu G, Oh JM, et al. Cerebral blood flow is diminished in asymptomatic middle-aged adults with maternal history of Alzheimer’s disease. Cereb Cortex 2014; 24: 978–988.
31. Tai LM, Thomas R, Marottoli FM, et al. The role of APOE in cerebrovascular dysfunction. Acta Neuropathol 2016; 131: 709–723.
32. Fletcher E, Villeneuve S, Maillard P, et al. Beta-amyloid, hippocampal atrophy and their relation to longitudinal brain change in cognitively normal individuals. Neurobiol Aging 2016; 40: 173–180.
33. de la Torre JC. Vascular basis of Alzheimer’s pathogenesis. Ann N Y Acad Sci 2002; 977: 196–215.
34. de la Torre JC. Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia. Cardiovasc Psychiatry Neurol 2012; 2012: 367516.
35. Toda N, Okamura T. Cerebral blood flow regulation by nitric oxide in Alzheimer’s disease. J Alzheimers Dis 2012; 32: 569–578.
36. Toda N, Ayajiki K, Okamura T. Obesity-induced cerebral hypoperfusion derived from endothelial dysfunction: one of the risk factors for Alzheimer’s disease. Curr Alzheimer Res 2014; 11: 733–744.
37. Katakam PV, Snipes JA, Steed MM, et al. Insulin-induced generation of reactive oxygen species and uncoupling of nitric oxide synthase underlie the cerebrovascular insulin resistance in obese rats. J Cereb Blood Flow Metab 2012; 32: 792–804.
38. Contreras C, Sanchez A, Garcia-Sacristan A, et al. Preserved insulin vasorelaxation and up-regulation of the Akt/eNOS pathway in coronary arteries from insulin resistant obese Zucker rats. Atherosclerosis 2011; 217: 331–339.
39. Grayson TH, Chadha PS, Bertrand PP, et al. Increased caveolae density and caveolin-1 expression accompany impaired NO-mediated vasorelaxation in diet-induced obesity. Histochem Cell Biol 2013; 139: 309–321.
40. Jennings JR, Heim AF, Kuan DC, et al. Use of total cerebral blood flow as an imaging biomarker of known cardiovascular risks. Stroke 2013; 44: 2480–2485.
41. Rusinek H, Ha J, Yau PL, et al. Cerebral perfusion in insulin resistance and type 2 diabetes. J Cereb Blood Flow Metab 2015; 35: 95–102.
42. Chytilová E, Malík J, Kasalová Z, et al. Lower wall shear rate of the common carotid artery in treated type 2 diabetes mellitus with metabolic syndrome. Physiol Res 2009; 58: 185–191.
43. Harrell JW, Morgan BJ, Schrage WG. Impaired hypoxic cerebral vasodilation in younger adults with metabolic syndrome. Diab Vasc Dis Res 2013; 10: 135–142.
44. Harrell JW, Schrage WG. Cyclooxygenase-derived vasoconstriction restrains hypoxia-mediated cerebral vasodilation in young adults with metabolic syndrome. Am J Physiol Heart Circ Physiol 2014; 306: H261–H269.